Introduction:

Chronic lymphoid leukemia is a chronic lymphoproliferative neoplasm characterized by the increase of a dysfunctional lymphoid clonal population with immunophenotype B (> 95%) and exceptionally T (<5%), it mainly affects people over 55 years of age, increasing towards the seventh decade of life.

Objective:

To analyze the main therapeutic modalities for the management of chronic lymphoid leukemia.

Methods:

A literature review was carried out, in English and Spanish, through the PubMed website and the academic search engine Google for articles published in the last 5 years. An analysis and summary of the revised bibliography was made.

Analysis and synthesis of the information:

Chronic lymphoid leukemia was considered for decades a disease of the elderly patient, generally of an indolent course, unpredictable and incurable evolution. The treatment of this disease has undergone in the last 30 years very significant changes that have had a favorable impact on the increase in the overall and disease-free survival of patients who suffer from it.

Conclusion:

Adequate follow-up of patients with chronic lymphoid leukemia must be maintained, as this will make it possible to reduce complications, progression and increase overall survival as much as possible.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )